FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4254055538> ?p ?o ?g. }

• W4254055538 endingPage "1551" @default.
• W4254055538 startingPage "1543" @default.
• W4254055538 abstract "Postmenopausal women who use hormone-replacement therapy (HRT) containing oestrogen alone are at increased risk of endometrial cancer. To minimise this risk, many HRT users who have not had a hysterectomy use combined oestrogen-progestagen preparations or tibolone. Limited information is available on the incidence of endometrial cancer in users of these therapies.716,738 postmenopausal women in the UK without previous cancer or previous hysterectomy were recruited into the Million Women Study in 1996-2001, provided information about their use of HRT and other personal details, and were followed up for an average of 3.4 years, during which time 1320 incident endometrial cancers were diagnosed.320,953 women (45%) reported at recruitment that they had used HRT, among whom 69,577 (22%) last used continuous combined therapy (progestagen added daily to oestrogen), 145,486 (45%) last used cyclic combined therapy (progestagen added to oestrogen, usually for 10-14 days per month), 28,028 (9%) last used tibolone, and 14,204 (4%) last used oestrogen-only HRT. These HRT types had sharply contrasting effects on the overall risk of endometrial cancer (p<0.0001 for heterogeneity). Compared with never users of HRT, risk was: reduced with last use of continuous combined preparations (relative risk 0.71 [95% CI 0.56-0.90]; p=0.005); increased with last use of tibolone (1.79 [1.43-2.25]; p<0.0001) and oestrogen only (1.45 [1.02-2.06]; p=0.04); and not significantly altered with last use of cyclic combined preparations (1.05 [0.91-1.22]; p=0.5). A woman's body-mass index significantly affected these associations, such that the adverse effects of tibolone and oestrogen-only HRT were greatest in non-obese women, and the beneficial effects of combined HRT were greatest in obese women.Oestrogens and tibolone increase the risk of endometrial cancer. Progestagens counteract the adverse effect of oestrogens on the endometrium, the effect being greater the more days every month that they are added to oestrogen and the more obese that women are. However, combined oestrogen-progestagen HRT causes a greater increase in breast cancer than the other therapies do. Thus, when endometrial and breast cancers are added together, there is a greater increase in total cancer incidence with use of combined HRT, both continuous and cyclic, than with use of the other therapies." @default.
• W4254055538 created "2022-05-12" @default.
• W4254055538 date "2005-04-01" @default.
• W4254055538 modified "2023-10-04" @default.
• W4254055538 title "Endometrial cancer and hormone-replacement therapy in the Million Women Study" @default.
• W4254055538 cites W1861209549 @default.
• W4254055538 cites W1976630275 @default.
• W4254055538 cites W1984386574 @default.
• W4254055538 cites W2016469228 @default.
• W4254055538 cites W2016677964 @default.
• W4254055538 cites W2027411808 @default.
• W4254055538 cites W2036044692 @default.
• W4254055538 cites W2051881327 @default.
• W4254055538 cites W2069877304 @default.
• W4254055538 cites W2069883047 @default.
• W4254055538 cites W2075506379 @default.
• W4254055538 cites W2077920472 @default.
• W4254055538 cites W2079450135 @default.
• W4254055538 cites W2086880154 @default.
• W4254055538 cites W2087552682 @default.
• W4254055538 cites W2126845172 @default.
• W4254055538 cites W2159416286 @default.
• W4254055538 cites W2191186928 @default.
• W4254055538 cites W2515721699 @default.
• W4254055538 cites W4240296991 @default.
• W4254055538 cites W4248618049 @default.
• W4254055538 doi "https://doi.org/10.1016/s0140-6736(05)66455-0" @default.
• W4254055538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15866308" @default.
• W4254055538 hasPublicationYear "2005" @default.
• W4254055538 type Work @default.
• W4254055538 citedByCount "471" @default.
• W4254055538 countsByYear W42540555382012 @default.
• W4254055538 countsByYear W42540555382013 @default.
• W4254055538 countsByYear W42540555382014 @default.
• W4254055538 countsByYear W42540555382015 @default.
• W4254055538 countsByYear W42540555382016 @default.
• W4254055538 countsByYear W42540555382017 @default.
• W4254055538 countsByYear W42540555382018 @default.
• W4254055538 countsByYear W42540555382019 @default.
• W4254055538 countsByYear W42540555382020 @default.
• W4254055538 countsByYear W42540555382021 @default.
• W4254055538 countsByYear W42540555382022 @default.
• W4254055538 countsByYear W42540555382023 @default.
• W4254055538 crossrefType "journal-article" @default.
• W4254055538 hasConcept C120665830 @default.
• W4254055538 hasConcept C121332964 @default.
• W4254055538 hasConcept C121608353 @default.
• W4254055538 hasConcept C126322002 @default.
• W4254055538 hasConcept C131872663 @default.
• W4254055538 hasConcept C141071460 @default.
• W4254055538 hasConcept C2777088508 @default.
• W4254055538 hasConcept C2777457466 @default.
• W4254055538 hasConcept C2778562196 @default.
• W4254055538 hasConcept C2779279991 @default.
• W4254055538 hasConcept C2779494336 @default.
• W4254055538 hasConcept C2780159708 @default.
• W4254055538 hasConcept C2780275930 @default.
• W4254055538 hasConcept C29456083 @default.
• W4254055538 hasConcept C3018603563 @default.
• W4254055538 hasConcept C530470458 @default.
• W4254055538 hasConcept C61511704 @default.
• W4254055538 hasConcept C71924100 @default.
• W4254055538 hasConceptScore W4254055538C120665830 @default.
• W4254055538 hasConceptScore W4254055538C121332964 @default.
• W4254055538 hasConceptScore W4254055538C121608353 @default.
• W4254055538 hasConceptScore W4254055538C126322002 @default.
• W4254055538 hasConceptScore W4254055538C131872663 @default.
• W4254055538 hasConceptScore W4254055538C141071460 @default.
• W4254055538 hasConceptScore W4254055538C2777088508 @default.
• W4254055538 hasConceptScore W4254055538C2777457466 @default.
• W4254055538 hasConceptScore W4254055538C2778562196 @default.
• W4254055538 hasConceptScore W4254055538C2779279991 @default.
• W4254055538 hasConceptScore W4254055538C2779494336 @default.
• W4254055538 hasConceptScore W4254055538C2780159708 @default.
• W4254055538 hasConceptScore W4254055538C2780275930 @default.
• W4254055538 hasConceptScore W4254055538C29456083 @default.
• W4254055538 hasConceptScore W4254055538C3018603563 @default.
• W4254055538 hasConceptScore W4254055538C530470458 @default.
• W4254055538 hasConceptScore W4254055538C61511704 @default.
• W4254055538 hasConceptScore W4254055538C71924100 @default.
• W4254055538 hasIssue "9470" @default.
• W4254055538 hasLocation W42540555381 @default.
• W4254055538 hasLocation W42540555382 @default.
• W4254055538 hasOpenAccess W4254055538 @default.
• W4254055538 hasPrimaryLocation W42540555381 @default.
• W4254055538 hasRelatedWork W117953448 @default.
• W4254055538 hasRelatedWork W1602864193 @default.
• W4254055538 hasRelatedWork W1845974318 @default.
• W4254055538 hasRelatedWork W1967183750 @default.
• W4254055538 hasRelatedWork W1978394592 @default.
• W4254055538 hasRelatedWork W2166258982 @default.
• W4254055538 hasRelatedWork W2466353041 @default.
• W4254055538 hasRelatedWork W4205911342 @default.
• W4254055538 hasRelatedWork W4238968764 @default.
• W4254055538 hasRelatedWork W4254055538 @default.
• W4254055538 hasVolume "365" @default.
• W4254055538 isParatext "false" @default.
• W4254055538 isRetracted "false" @default.

• next